 |
인쇄하기
취소
|
Government to spend 3.8 bn over R&D of Ilyang’s leukemia medicine
The government plans to earmark 3.8 billion won for Ilyang Pharm’s new leukemia treatment candidate IY5511 that has the potential to be used as a drug, it was announced on November 24.
The Korea Health Industry Development Institute said that IY5511 has been selected as one of the state-funded research projects in the latter of this year.
Ilyang Pharm says it has conducted Phase I and II ...
The Korea Health Industry Development Institute said that IY5511 has been selected as one of the state-funded research projects in the latter of this year.
Ilyang Pharm says it has conducted Phase I and II ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.